Literature DB >> 23289181

Using a filtration technique to isolate platelet free plasma for assaying pyrophosphate.

Ramin Tolouian1, Sean M Connery, W Charles O'Neill, Ajay Gupta.   

Abstract

BACKGROUND: Vascular calcification (VC) is a strong prognostic marker of mortality from cardiovascular disease. Extracellular inorganic pyrophosphate (PPi) is a critical inhibitor of vascular calcification and it has been reported that hemodialysis patients have reduced plasma PPi levels, suggesting that altered PPi metabolism could contribute to VC in hemodialysis patients. Platelets are rich in PPi and release of PPi from platelets during storage or processing of plasma can lead to falsely elevated plasma PPi levels. To prepare plasma samples that are suitable for measuring PPi levels, ultracentrifugation has been used to remove platelets. Consequently, plasma PPi measurements have been limited to research laboratories since the majority of clinical laboratories do not have access to an ultracentrifuge. The purpose of the present study was to test the validity of an improved method of preparing platelet free plasma that uses filtration with a 300,000 Dalton molecular weight cut-off filter to exclude platelets, while minimizing their release of PPi.
METHODS: In 20 maintenance hemodialysis patients, PPi levels were measured in plasma samples prepared by the conventional technique of low-speed centrifugation to remove red and white blood cells versus a novel filtration technique.
RESULTS: Plasma prepared by filtration had significantly lower platelet counts (0 vs. 3 - 7 10(3)/microL) and PPi levels (1.39 +/- 0.30 microM vs. 2.74 +/- 1.19 microM; mean +/- SD, p < 0.01).
CONCLUSIONS: The filtration method appears effective in excluding platelets without causing trauma to platelets and can be used by clinical laboratories to prepare platelet-depleted plasma for PPi measurement.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23289181      PMCID: PMC4733525     

Source DB:  PubMed          Journal:  Clin Lab        ISSN: 1433-6510            Impact factor:   1.138


  18 in total

1.  Quantification of human plasma inorganic pyrophosphate. II. Biologic variables.

Authors:  L M Ryan; F Kozin; D J McCarty
Journal:  Arthritis Rheum       Date:  1979-08

2.  Analysis of inorganic pyrophosphate at the picomole level.

Authors:  C P Cheung; R J Suhadolnik
Journal:  Anal Biochem       Date:  1977-11       Impact factor: 3.365

3.  Relationship between pyrophosphate, amorphous calcium phosphate and other factors in the sequence of calcification in vivo.

Authors:  R E Wuthier; S Bisaz; R G Russell; H Fleisch
Journal:  Calcif Tissue Res       Date:  1972

Review 4.  A review of the physiological and pharmacological effects of pyrophosphate and diphosphonates on bones and teeth.

Authors:  H Fleisch; R G Russell
Journal:  J Dent Res       Date:  1972 Mar-Apr       Impact factor: 6.116

5.  The concentration of inorganic pyrophosphate in human saliva and dental calculus.

Authors:  E Hausmann; S Bisaz; R G Russel; H Fleisch
Journal:  Arch Oral Biol       Date:  1970-12       Impact factor: 2.633

6.  Reduced plasma pyrophosphate levels in hemodialysis patients.

Authors:  Koba A Lomashvili; Wassim Khawandi; W Charles O'Neill
Journal:  J Am Soc Nephrol       Date:  2005-06-15       Impact factor: 10.121

7.  Measurement of inhibitors of calcium phosphate precipitation in plasma ultrafiltrate.

Authors:  H S Rüfenacht; H Fleisch
Journal:  Am J Physiol       Date:  1984-05

8.  Extraosseous calcification. Evidence for abnormal pyrophosphate metabolism in uremia.

Authors:  A C Alfrey; C C Solomons; J Ciricillo; N L Miller
Journal:  J Clin Invest       Date:  1976-03       Impact factor: 14.808

Review 9.  Vascular calcifications in uremia: old concepts and new insights.

Authors:  Ulver Derici; A Meguid El Nahas
Journal:  Semin Dial       Date:  2006 Jan-Feb       Impact factor: 3.455

10.  Identification of inorganic pyrophosphate in human platelets and its release on stimulation with thrombin.

Authors:  D C Silcox; S Jacobelli; D J McCarty
Journal:  J Clin Invest       Date:  1973-07       Impact factor: 14.808

View more
  8 in total

Review 1.  PXE, a Mysterious Inborn Error Clarified.

Authors:  Piet Borst; András Váradi; Koen van de Wetering
Journal:  Trends Biochem Sci       Date:  2018-11-13       Impact factor: 13.807

2.  Plasma PPi Deficiency Is the Major, but Not the Exclusive, Cause of Ectopic Mineralization in an Abcc6-/- Mouse Model of PXE.

Authors:  Jingyi Zhao; Joshua Kingman; John P Sundberg; Jouni Uitto; Qiaoli Li
Journal:  J Invest Dermatol       Date:  2017-06-23       Impact factor: 8.551

3.  Abcc6 Knockout Rat Model Highlights the Role of Liver in PPi Homeostasis in Pseudoxanthoma Elasticum.

Authors:  Qiaoli Li; Joshua Kingman; Koen van de Wetering; Sami Tannouri; John P Sundberg; Jouni Uitto
Journal:  J Invest Dermatol       Date:  2017-01-19       Impact factor: 8.551

4.  Juxta-articular joint-capsule mineralization in CD73 deficient mice: similarities to patients with NT5E mutations.

Authors:  Qiaoli Li; Thea P Price; John P Sundberg; Jouni Uitto
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

5.  Spontaneous asj-2J mutant mouse as a model for generalized arterial calcification of infancy: a large deletion/insertion mutation in the Enpp1 gene.

Authors:  Qiaoli Li; C Herbert Pratt; Louise A Dionne; Heather Fairfield; Son Yong Karst; John P Sundberg; Jouni Uitto
Journal:  PLoS One       Date:  2014-12-05       Impact factor: 3.240

6.  Alkaline Phosphatases Account for Low Plasma Levels of Inorganic Pyrophosphate in Chronic Kidney Disease.

Authors:  Audrey Laurain; Isabelle Rubera; Christophe Duranton; Frank Rutsch; Yvonne Nitschke; Elodie Ray; Sandor Vido; Antoine Sicard; Georges Lefthériotis; Guillaume Favre
Journal:  Front Cell Dev Biol       Date:  2020-12-03

7.  Plasma inorganic pyrophosphate and alkaline phosphatase in patients with pseudoxanthoma elasticum.

Authors:  Ana María Sánchez-Tévar; María García-Fernández; Belén Murcia-Casas; José Rioja-Villodres; Juan Luis Carrillo; Marta Camacho; Matthias Van Gils; Miguel Angel Sánchez-Chaparro; Olivier Vanakker; Pedro Valdivielso
Journal:  Ann Transl Med       Date:  2019-12

8.  Bone turnover and mineral metabolism in adult patients with hypophosphatasia treated with asfotase alfa.

Authors:  L Seefried; D Rak; A Petryk; F Genest
Journal:  Osteoporos Int       Date:  2021-07-02       Impact factor: 4.507

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.